Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Self-Evaluation: Self-Enhancement and Self-Verification03:00

Self-Evaluation: Self-Enhancement and Self-Verification

5.8K
Social psychologists have documented that feeling good about ourselves and maintaining positive self-esteem is a powerful motivator of human behavior (Tavris & Aronson, 2008). In the United States, members of the predominant culture typically think very highly of themselves and view themselves as good people who are above average on many desirable traits (Ehrlinger, Gilovich, & Ross, 2005). Often, our behavior, attitudes, and beliefs are affected when we experience a threat to our...
5.8K
Autophagic Cell Death01:18

Autophagic Cell Death

4.6K
Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
4.6K
Overview of Cell Death01:30

Overview of Cell Death

10.2K
Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
10.2K
Bioavailability Enhancement: Drug Solubility Enhancement01:16

Bioavailability Enhancement: Drug Solubility Enhancement

273
Body:Bioavailability is a critical factor in determining a drug's effectiveness. It refers to the proportion of a drug that enters the circulation when introduced into the body and is, as a result, able to have an active effect. Enhancing bioavailability is essential for drugs with poor solubility, as it can significantly impact their therapeutic efficacy. Various methods are employed to increase the solubility of drugs, thereby enhancing their bioavailability.Micronization and nanonization are...
273
Bioavailability Enhancement: Drug Permeability Enhancement01:27

Bioavailability Enhancement: Drug Permeability Enhancement

213
Body:After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt...
213
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention01:05

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

226
Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
226

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Differential Associations Between Passive and Interactive Screentime and Sleep Duration Among 8th and 11th Grade Adolescents.

Children (Basel, Switzerland)·2026
Same author

Noncardiovascular Medical Conditions in the Pregnancy Mortality Surveillance System, 2012-2022.

Obstetrics and gynecology·2026
Same author

Pregnancy-Related Mortality Due to Infection: Maternal Mortality Review Committees in 29 U.S. States, 2017-2019.

Obstetrics and gynecology·2026
Same author

Common Complications and Conditions at Delivery Hospitalization by Race and Ethnicity in the United States.

Obstetrics and gynecology·2025
Same author

Pregnancy-Related Deaths Due to Infection: Pregnancy Mortality Surveillance System, 2012-2019.

Obstetrics and gynecology·2025
Same author

Cardiomyopathy Prevalence and Pregnancy-Related Mortality: United States, 2010 to 2020.

JACC. Advances·2025
Same journal

A Quality-Improvement Study Evaluating Three Postpartum Prophylactic Oxytocin Rates and Blood Loss After Vaginal Birth.

Obstetrics and gynecology·2026
Same journal

The Effects of Climate Change on Obstetric and Gynecologic Health.

Obstetrics and gynecology·2026
Same journal

PUBLICATIONS: July 2026.

Obstetrics and gynecology·2026
Same journal

Vaginal Natural Orifice Transluminal Endoscopic Surgery in Minimally Invasive Gynecologic Surgery: Correction.

Obstetrics and gynecology·2026
Same journal

A Contemporary View of Menopausal Hormone Therapy: Correction.

Obstetrics and gynecology·2026
Same journal

In Reply.

Obstetrics and gynecology·2026
See all related articles

Related Experiment Video

Updated: Feb 12, 2026

Determining the Role of Maternally-Expressed Genes in Early Development with Maternal Crispants
10:08

Determining the Role of Maternally-Expressed Genes in Early Development with Maternal Crispants

Published on: December 21, 2021

2.6K

Identifying Maternal Deaths in Texas Using an Enhanced Method, 2012.

Sonia Baeva1, Debra L Saxton, Karen Ruggiero

  • 1Division for Community Health Improvement, Texas Department of State Health Services, Austin, the Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, and the Texas Department of State Health Services, Austin, Texas.

Obstetrics and Gynecology
|April 10, 2018
PubMed
Summary
This summary is machine-generated.

An enhanced method for identifying maternal deaths in Texas revealed a significantly lower maternal mortality ratio than previously reported. This improved approach, using data matching and record review, offers more accurate vital statistics for maternal health surveillance.

More Related Videos

MEDUSA for Identifying Death Regulatory Genes in Chemo-genetic Profiling Data
07:17

MEDUSA for Identifying Death Regulatory Genes in Chemo-genetic Profiling Data

Published on: February 7, 2025

935
Generation of Maternal Mutants Using zpc:cas9 Knock-in Zebrafish
09:17

Generation of Maternal Mutants Using zpc:cas9 Knock-in Zebrafish

Published on: July 22, 2025

858

Related Experiment Videos

Last Updated: Feb 12, 2026

Determining the Role of Maternally-Expressed Genes in Early Development with Maternal Crispants
10:08

Determining the Role of Maternally-Expressed Genes in Early Development with Maternal Crispants

Published on: December 21, 2021

2.6K
MEDUSA for Identifying Death Regulatory Genes in Chemo-genetic Profiling Data
07:17

MEDUSA for Identifying Death Regulatory Genes in Chemo-genetic Profiling Data

Published on: February 7, 2025

935
Generation of Maternal Mutants Using zpc:cas9 Knock-in Zebrafish
09:17

Generation of Maternal Mutants Using zpc:cas9 Knock-in Zebrafish

Published on: July 22, 2025

858

Area of Science:

  • Public Health
  • Epidemiology
  • Maternal Health

Background:

  • Accurate estimation of maternal mortality ratios (MMR) is crucial for public health surveillance.
  • Traditional methods relying solely on obstetric cause-of-death codes may overestimate MMR due to coding inaccuracies.

Purpose of the Study:

  • To develop and apply an enhanced method for identifying maternal deaths in Texas for the year 2012.
  • To compare the MMR estimated by the enhanced method with that derived from the standard method using only obstetric codes.

Main Methods:

  • A population-based descriptive study was conducted.
  • Data matching and record review were employed to verify pregnancy status within 42 days of death for 147 cases with obstetric codes.
  • Additional maternal deaths were identified using data matching.

Main Results:

  • Fifty-six maternal deaths were confirmed.
  • The enhanced method yielded a 2012 Texas MMR of 14.6 deaths per 100,000 live births.
  • The standard method overestimated MMR, with nearly half of obstetric-coded deaths lacking evidence of recent pregnancy.

Conclusions:

  • Sole reliance on obstetric codes is insufficient for accurate MMR estimation.
  • An enhanced method incorporating data matching and record review provides more precise maternal mortality data.
  • Findings suggest potential inaccuracies in state-level MMR reporting nationwide due to miscoding.